pseudoephedrine has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, L; Chen, Y; Lin, G; Lin, H; Wang, M; Xiang, Y; Ye, W; Yu, S; Zhang, J; Zhang, P; Zhu, Y | 1 |
| Fayez, YM; Monir, HH; Mostafa, NM; Rostom, Y; Soliman, RM | 1 |
| Bogun, B; Craig, J; Larsen, A; Marr, B; Mayo, E; McKinnel, M; Russell, M; Watson, J | 1 |
| Bade, R; Gracia-Lor, E; Mueller, JF; Romero-Sánchez, I; Rousis, N; Thomaidis, NS; Thomas, KV | 1 |
1 review(s) available for pseudoephedrine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Novel Spectrophotometric Approaches for the Simultaneous Quantification of Ternary Common Cold Mixture Containing Paracetamol with a Challenging Formulation Ratio: Greenness Profile Evaluation.
Topics: Acetaminophen; Common Cold; Cough; COVID-19; Humans; Pseudoephedrine; Spectrophotometry | 2022 |
3 other study(ies) available for pseudoephedrine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect.
Topics: COVID-19; Humans; Protein Binding; Pseudoephedrine; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Trends of clandestine laboratories manufacturing methamphetamine in New Zealand between 2009-2021: Evolution, enforcement, legislative, and COVID-19 effects.
Topics: COVID-19; Ephedrine; Humans; Laboratories; Methamphetamine; New Zealand; Pandemics; Pseudoephedrine | 2023 |
Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
Topics: Cocaine; COVID-19; Heroin; Holidays; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Pandemics; Prevalence; Pseudoephedrine; Psychotropic Drugs; Substance-Related Disorders | 2023 |